undamentalytics Newsletter

Hessner Catherine: insider trades

Officer at Innospec Inc. 2 open-market purchases and 20 sales not made under a pre-set plan, reported from February 25, 2010 to May 13, 2021.

Would copying Hessner Catherine’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 2 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on February 26, 2010 into $34,686 by November 2, 2026, +7.8% a year. The copy held shares only 6% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $15,812, +2.8% a year (the S&P 500 held throughout made $91,761, +14.2% a year). Beta against the index was 0.07. Twelve months after each report, the average purchase was +68.4% against the S&P 500 (median +68.4%), and 100% beat it. Measured from the trade date, the insider’s own timing, the average was +64.1%. After their sales, the shares moved −2.0% against the index over 12 months on average (a negative figure means selling was the right call); 60% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$50.0k$100k 201020122014201620182020202220242026 $91.8k$34.7k$15.8k
Copying Hessner CatherineS&P 500, same days investedS&P 500, held throughout $10,000 copying Hessner Catherine’s open-market purchases from February 26, 2010, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
+7.8%
S&P 500, same days invested
+2.8% (held throughout +14.2%)
Time in shares
6%
Sharpe ratio (S&P 500)
0.58 (0.78)
Biggest drop (S&P 500)
−41% (−34%)
Market sensitivity (beta)
0.07
Purchases copied
2

Trade by trade

Hessner Catherine: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 2 +17.3% +17.3% 100% 2 — — Not enough years
Purchases, 6 months after the report 2 +6.7% +6.7% 50% 2 — — Not enough years
Purchases, 12 months after the report 2 +68.4% +68.4% 100% 2 — — Not enough years
Purchases, 12 months after the trade 2 +64.1% +64.1% 100% 2 — — Not enough years
Sales, 3 months after the report 20 −2.9% −2.3% 70% 11 −1.02 0.33 No reliable evidence
Sales, 12 months after the report 20 −2.0% −1.1% 60% 11 −0.27 0.79 No reliable evidence
Sales, 12 months after the trade 20 −1.9% −3.9% 55% 11 0.07 0.95 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Innospec Inc. IOSP Senior VP - Human Resources220February 25, 2010May 13, 2021

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 13, 2021May 10, 2021 IOSP Sale $185,167 −14.2%+3.4%+4.8%
May 11, 2021May 7, 2021 IOSP Sale $505,643 −12.7%+3.7%+0.9%
June 4, 2020June 2, 2020 IOSP Sale $222,290 −20.8%−12.0%−6.8%
November 13, 2019November 12, 2019 IOSP Sale $497,950 −1.5%−34.1%−38.3%
June 5, 2019June 4, 2019 IOSP Sale $167,272 −1.1%−13.1%−19.2%
February 25, 2019February 22, 2019 IOSP Sale $345,307 +1.4%−4.3%−4.2%
June 6, 2018June 5, 2018 IOSP Sale $227,678 −8.1%+1.0%+2.2%
February 27, 2018February 26, 2018 IOSP Sale $94,308 +18.4%+23.7%+19.2%
November 29, 2017November 28, 2017 IOSP Sale $50,593 −10.1%−1.4%−3.9%
March 21, 2017March 17, 2017 IOSP Sale $189,450 −1.6%−0.7%−3.9%
February 22, 2017February 17, 2017 IOSP Sale $259,814 −7.6%−16.1%−23.2%
November 23, 2016November 18, 2016 IOSP Sale $63,087 −9.3%−11.5%−10.8%
March 3, 2016March 2, 2016 IOSP Sale $63,729 +5.3%+25.7%+32.7%
May 12, 2015May 11, 2015 IOSP Sale $220,150 +4.6%+9.3%+10.3%
February 26, 2015February 24, 2015 IOSP Sale $221,519 −2.9%+5.7%+9.3%
February 27, 2014February 25, 2014 IOSP Sale $29,608 −6.3%−10.7%−13.3%
May 10, 2013May 9, 2013 IOSP Sale $214,721 +3.5%−8.7%−13.6%
February 28, 2013February 26, 2013 IOSP Sale $71,697 −8.7%−20.0%−12.8%
August 15, 2012August 13, 2012 IOSP Sale $104,664 −1.2%+19.5%+26.0%
March 7, 2011March 3, 2011 IOSP Sale $13,699 +15.6%−0.4%+7.2%
February 23, 2011February 18, 2011 IOSP Purchase $18,211 +17.1%+5.4%+6.3%
February 25, 2010February 23, 2010 IOSP Purchase $19,502 +17.5%+131.3%+121.8%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Hessner Catherine traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.